|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.53 USD | +5.30% |
|
+0.77% | -5.98% |
| Apr. 11 | Craig-Hallum Starts Harrow With Buy Rating, $24 Price Target | MT |
| Mar. 22 | B. Riley Securities Adjusts Harrow Health's Price Target to $26 From $30, Maintains Buy Rating | MT |
Harrow, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 130.19 million compared to USD 88.6 million a year ago. Net loss was USD 24.41 million compared to USD 14.09 million a year ago.
Basic loss per share from continuing operations was USD 0.75 compared to USD 0.51 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.98% | 372M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
HARROW, INC. 
